Jotec GmbH (Jotec), a subsidiary of Artivion, Inc, is a medical device company that develops, produces and markets implants for the treatment of vascular disease. Its product portfolio includes endovascular and surgical products. It offers thoracic stent grafts, thoracoabdominal stent grafts, abdominal stent grafts, peripheral stent grafts, e-xtra design engineering and surgical portfolio. The company offers hybrid stent graft system for optimized frozen elephant trunk procedure and next generation hybrid stent graft system for frozen elephant trunk technique. Jotec is headquartered in Hechingen, Baden-Wurttemberg, Germany.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company JOTEC GmbH
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- JOTEC GmbH Company Overview
- JOTEC GmbH Company Snapshot
- JOTEC GmbH Pipeline Products and Ongoing Clinical Trials Overview
- JOTEC GmbH - Pipeline Analysis Overview
- JOTEC GmbH - Key Facts
- JOTEC GmbH - Major Products and Services
- JOTEC GmbH Pipeline Products by Development Stage
- JOTEC GmbH Ongoing Clinical Trials by Trial Status
- JOTEC GmbH Pipeline Products Overview
- E-liac Stent Graft System
- E-liac Stent Graft System Product Overview
- E-liac Stent Graft System Clinical Trial
- E-nside TAAA Stent Graft
- E-nside TAAA Stent Graft Product Overview
- E-nside TAAA Stent Graft Clinical Trial
- E-nya Thoracic Stent Graft
- E-nya Thoracic Stent Graft Product Overview
- E-nya Thoracic Stent Graft Clinical Trial
- E-Ventus SX
- E-Ventus SX Product Overview
- E-Vita Open Neo
- E-Vita Open Neo Product Overview
- E-Vita Open Neo Clinical Trial
- JOTEC GmbH - Key Competitors
- JOTEC GmbH - Key Employees
- JOTEC GmbH - Locations And Subsidiaries
- Head Office
- Recent Developments
- JOTEC GmbH, Recent Developments
- May 30, 2023: ‘Korea Needs to Localize Rare Medical Devices Amid Global Supply Shortage’
- Mar 05, 2020: CryoLife secures CE Mark for hybrid stent graft system
- Dec 02, 2019: CryoLife receives CE mark for E-nya Thoracic Stent Graft
- Dec 02, 2019: CryoLife receives CE mark for E-nside thoraco-abdominal stent graft
- Jun 20, 2016: Great attendance at the E-vita OPEN PLUS Experts Meeting
- Jul 14, 2015: JOTEC Receives CE mark for E-vita THORACIC 3G Stent Graft System with Triple-P Technology
- Nov 12, 2014: JOTEC Receives CE mark for E-tegra Stent Graft System
- Feb 10, 2014: JOTEC Receives CE mark for E-ventus BX Peripheral Stent Graft System
- Jan 10, 2014: JOTEC Receives CE mark for E-liac Stent Graft System
- Dec 18, 2013: Green light for new device to treat complex disease of the main heart artery
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- JOTEC GmbH Pipeline Products and Ongoing Clinical Trials Overview
- JOTEC GmbH Pipeline Products by Indication
- JOTEC GmbH Ongoing Clinical Trials by Trial Status
- JOTEC GmbH, Key Facts
- JOTEC GmbH, Major Products and Services
- JOTEC GmbH Number of Pipeline Products by Development Stage
- JOTEC GmbH Pipeline Products Summary by Development Stage
- JOTEC GmbH Ongoing Clinical Trials by Trial Status
- JOTEC GmbH Ongoing Clinical Trials Summary
- E-liac Stent Graft System - Product Status
- E-liac Stent Graft System - Product Description
- E-liac Stent Graft System - Prospective Multicenter Registry to Examine the Real-world Performance of the E-liac Stent Graft System for Treatment of Uni - or Bilateral Aorto-iliac or Iliac Aneurysms
- E-liac Stent Graft System - Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm with the Branched E-liac Stent Graft
- E-nside TAAA Stent Graft - Product Status
- E-nside TAAA Stent Graft - Product Description
- E-nside TAAA Stent Graft - INNER-B - A Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System
- E-nside TAAA Stent Graft - INNER-B-APAC - Asian Pacific Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System
- E-nya Thoracic Stent Graft - Product Status
- E-nya Thoracic Stent Graft - Product Description
- E-nya Thoracic Stent Graft - CONFORM-TAA - A Post-market Clinical Follow-up Study in Patients with a Descending Thoracic Aortic Aneurysm or Penetrating Aortic Ulcer (PAU) Treated with the E-nya Thoracic Stent Graft System
- E-nya Thoracic Stent Graft - CONFORM-TAD - A Post-market Clinical Follow-up Study in Patients with Complicated Acute, Subacute or Chronic Type B Aortic Dissection with Double Lumen Treated with the E-nya Thoracic Stent Graft System
- E-Ventus SX - Product Status
- E-Ventus SX - Product Description
- E-Vita Open Neo - Product Status
- E-Vita Open Neo - Product Description
- E-Vita Open Neo - A Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO: NEOS
- E-Vita Open Neo - NEO - E-vita Open Neo Treatment of Aortic Arch Aneurysms and Dissections
- E-Vita Open Neo - NEOS-APAC - Asian Pacific Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO
- JOTEC GmbH, Key Employees
- Glossary
- JOTEC GmbH Pipeline Products by Equipment Type
- JOTEC GmbH Pipeline Products by Development Stage
- JOTEC GmbH Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Admedes GmbH
- Vacis BV
- Translumina GmbH
- Joline GmbH & Co KG
